The multiple roles of phosphoinositide 3-kinase in mast cell biology
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 29 (10) , 493-501
- https://doi.org/10.1016/j.it.2008.07.004
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disordersBritish Journal of Pharmacology, 2008
- Synergistic activation of phospholipases Cγ and Cβ: A novel mechanism for PI3K-independent enhancement of FcεRI-induced mast cell mediator releaseCellular Signalling, 2008
- G protein-coupled receptors and the modification of FcɛRI-mediated mast cell activationImmunology Letters, 2007
- Genetic and pharmacologic evidence implicating the p85α, but not p85β, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosisBlood, 2007
- Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3KTrends in Immunology, 2007
- An essential role for RasGRP1 in mast cell function and IgE-mediated allergic responseThe Journal of Experimental Medicine, 2006
- Stress and mTORture signalingOncogene, 2006
- Structure and regulation of Kit protein-tyrosine kinase—The stem cell factor receptorBiochemical and Biophysical Research Communications, 2005
- BTK Regulates PtdIns-4,5-P2 SynthesisImmunity, 2003
- Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunitCancer Cell, 2002